| Name | Title | Contact Details |
|---|
Harvard Pilgrim Health Care is a full-service health benefits company serving more than one million members throughout Massachusetts, New Hampshire, Maine, Connecticut, and beyond. We`re dedicated to improving the quality and value of health care for the people and communities we serve. We recognize that health care is not one size fits all, and we`re working every day to create value for our members by respecting their unique values, languages, and cultures. For more than 40 years, we have built a reputation for exceptional clinical quality, preventive care, disease management, and member satisfaction, and have consistently been rated among the top plans in the country. In 2013 Harvard Pilgrim Health Care was ranked #1 private health plan in America for the 10th consecutive year. (#1 plan information available at http://countusin.harvardpilgrim.org/privacy) An independent, not-for-profit organization known for innovation that delivers better health and cost management, Harvard Pilgrim offers a wide variety of health insurance options for companies, families, and individuals. Our fully-insured and self-insured PPO, POS, and HMO plans are available with multiple variations tailored to the needs of our members and their employers. So, wherever, whenever you are looking for a partner in health benefits, or a great place to work, count us in. Harvard Pilgrim Health Care includes Harvard Pilgrim Health Care, Harvard Pilgrim Health Care of New England, and HPHC Insurance Company.
Automated Group Administration, Inc. is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Health & Company is a Roswell, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Comprehensive NeuroScience, Inc. is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.